ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1350	National Cancer Institute	Html	en	Adult Central Nervous System Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult central nervous system tumors.	treatment 0.515559 malignant tumor cells 0.227722 general information 0.262069 NCI-supported cancer 0.222651 cancer cells 0.27674 type 0.244277 spinal cord tumors 0.473603 clinical trial search 0.391071 brain tumors 0.2801 spinal cord 0.914442 tumor cells 0.493038 normal cells 0.296092	clinical trial 0.432056 clinical trials 0.701078 brain tumor 0.235359 brain 0.738045 PDQ summary 0.285532 tumors 0.535252 cancer clinical trials 0.361596 tumor 0.77091 radiation therapy 0.479169 grade 0.218633 cancer 0.578346 information 0.296506	CLICK HERE
1460	National Cancer Institute	Html	en	Adjustment to Cancer: Anxiety and Distress (PDQ®)–Health Professional Version	Expert-reviewed information summary about the difficult emotional responses many cancer patients experience. This summary focuses on normal adjustment issues, psychosocial distress, and adjustment disorders.	cancer treatment 0.348496 adjustment disorders 0.377426 newly diagnosed cancer 0.338474 palliative care specialist 0.336033 emotional distress 0.481089 recurrent breast cancer 0.355658 ambulatory cancer patients 0.342576 psychological distress 0.361971 Japanese cancer patients 0.3428 Cancer Network Distress 0.42624 early-stage breast cancer 0.450601 adult cancer patients 0.342011 posttreatment distress 0.33562 health care professionals 0.348864 normal adjustment 0.438186 adolescent cancer patients 0.355821 social support 0.338806 breast cancer patients 0.4182 patients 0.62456 cancer patients 0.6025 normal adjustment issues 0.349617 cancer diagnosis 0.33963 breast cancer survivors 0.37097 mental disorders 0.352228 psychosocial distress 0.487249	adjustment 0.494267 women 0.328737 distress 0.685449 psychosocial assessment 0.364194 study 0.349859 distress scores 0.331169 stage breast cancer 0.326706 breast cancer diagnosis 0.330404 palliative care 0.44264 cancer-related life events 0.334421 life 0.404419 posttreatment cancer-related distress 0.396788 general distress indices 0.342126 primary oncology team 0.360914 diagnostic criteria 0.346926 psychosocial assessment interview 0.338281 Community Cancer Care 0.328482 advanced cancer 0.337588 breast cancer 0.994793 mental disorder 0.347463 psychological well-being 0.349655 Psychosocial Distress section 0.403402 general distress 0.349587 major depressive disorder 0.329474	CLICK HERE
1590	National Cancer Institute	Html	en	Adjustment to Cancer: Anxiety and Distress (PDQ®)–Patient Version	Expert-reviewed information summary about the difficult emotional responses many cancer patients experience. This summary focuses on normal adjustment issues, psychosocial distress, and adjustment disorders.	cancer treatment 0.390955 mental health 0.376414 emotional distress 0.342467 mild anxiety 0.297125 Anxiety disorder—A condition 0.322854 long-term cancer survivors 0.290225 following PDQ summaries 0.289376 PDQ cancer information 0.401693 clinical trial search 0.290488 clinical trials 0.374063 cancer information summary 0.360243 normal adjustment 0.315173 Cancer education sessions 0.292812 patients 0.858745 cancer diagnosis 0.420677 mental health problem 0.344798 symptoms 0.369957 anxiety 0.674027 NCI PDQ cancer 0.318604 cancer survivors 0.307582 anxiety disorder 0.421462 great anxiety 0.289049 problems 0.310639 distress 0.498316 treatment 0.584321	cancer prevention 0.287279 NCI-supported cancer 0.289072 palliative care 0.307485 Cancer Information Service 0.302564 life 0.319995 generalized anxiety disorder 0.307665 cancer patients 0.396085 National Cancer Institute 0.357347 Cancer Care 0.313891 adjustment disorder 0.323889 Palliative Care Editorial 0.287821 Cancer Care page 0.291913 Care Editorial Board 0.290774 anxiety disorders 0.412812 stressful event 0.352734 fast heart beat 0.32985 PDQ summary 0.441306 intense anxiety 0.302865 cancer clinical trials 0.331141 cancer information summaries 0.300508 comprehensive cancer information 0.300154 cancer 0.962959 information 0.418397 depression 0.295223	CLICK HERE
1754	National Cancer Institute	Html	en	Breast Reconstruction After Mastectomy	A fact sheet that describes breast reconstruction after mastectomy, including surgical options, follow-up care, and breast cancer screening after reconstruction.	breast reduction surgery 0.28849 tissue breast reconstruction 0.452019 flap reconstruction 0.330223 immediate reconstruction 0.31662 tissue 0.60196 breast reconstruction surgery 0.457163 mastectomy 0.359177 implant 0.307847 implant reconstruction 0.254395 breast numbness 0.249047 donor tissue 0.258639 breast skin 0.288491 early-stage breast cancer 0.279638 natural breast shape 0.273514 pedicled flap reconstruction 0.298564 autologous tissue reconstruction 0.366797 breast cancer experience 0.279508 reconstructed breast 0.419512 autologous reconstruction 0.246473 tissue expander 0.25279 blood vessels 0.426971 chest wall tissue 0.239092 entire breast 0.302278 Delayed reconstruction 0.247408 breast cancer therapy 0.323533	radiation therapy 0.283075 breast reconstruction technique 0.360333 breast forms 0.256638 external breast prostheses 0.334034 women 0.280496 surgical nipple reconstruction 0.280177 breast reconstruction method 0.374498 breast reconstruction 0.909174 breast rebuilt 0.281588 free flap reconstruction 0.325097 breast cancer recurrence 0.30156 woman considering breast 0.279422 breast tissue 0.318522 flap 0.344123 sufficient breast volume 0.289888 autologous tissue 0.583784 Breast Implants page 0.303495 breast surgeons 0.246995 breast area 0.280597 breast cancer 0.510147 skin-sparing mastectomy 0.235094 Breast Disease 0.251106 inflammatory breast cancer 0.289892 chest tissue 0.237416	CLICK HERE
1998	National Cancer Institute	Html	es	Grados de comprobación científica de los estudios de cuidados médicos de apoyo (PDQ®)–Versión para profesionales de salud	Información acerca de cómo evaluar la solidez de los datos probatorios obtenidos en los estudios de cuidados médicos de apoyo y cuidados paliativos.	Visuals Online 0.744337 siguientes aspectos 0.811238 conclusiones contradictorias 0.784508 Physician Data Query 0.788451 mejores datos 0.935432 siguientes parámetros 0.783558 siguientes fuentes 0.801613 quizás estén 0.788541	bibliografía biomédica 0.790209 siguientes datos 0.810319 National Cancer Institute 0.778122 numerosos sesgos 0.778964 siguientes riesgos 0.757344 determinado grupo 0.761778 siguientes temas 0.815552 Instituto Nacional 0.963601	CLICK HERE
2113	National Cancer Institute	Html	es	Exámenes de detección del cáncer de hígado (hepatocelular) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de hígado (hepatocelular).	chronic hepatitis b 0.350732 Cancer Res Clin 0.309514 cirrhotic patients monitored 0.308745 surgical treatment 0.304976 cases with 0.308289 Caucasian patients with 0.312453 CT-based tumor detection 0.30733 American Cancer Society 0.308532 infected with chronic 0.311933 clara preponderancia masculina 0.307413 patients with cirrhosis 0.329337 primary biliary cirrhosis 0.309915 to hepatocellular carcinoma 0.346439 Stroffolini T 0.311275 hepatocellular carcinoma 0.916421 Concurrent hepatitis 0.313581 Instituto Nacional 0.316611 risk factors 0.314635 PDQ Exámenes 0.318741 azar pacientes 0.307637 population-based study 0.305586 Baron RL 0.310966 Estados Unidos 0.349629 Serum tumor markers 0.306902 Cochrane Database Syst 0.306527	múltiples estudios 0.311385 patients with 0.460866 Fattovich G 0.312507 viral cirrhosis 0.306776 with chronic hepatitis 0.35842 screening technique 0.309776 identificó chc 0.327158 Prospective evaluation 0.305469 Sherman M 0.309865 Marsh JW Jr 0.306291 escasas ocasiones 0.326921 Expert Rev Anticancer 0.307784 National Cancer Institute 0.308331 serum alpha-fetoprotein levels 0.308165 Silent cirrhosis 0.306117 Aflatoxinas Asia 0.305041 De Maria N 0.306597 Physician Data Query 0.306315 etiología viral 0.305508 Horlander JC Sr 0.306639 alcoholic cirrhosis 0.306717 cáncer hepatocelular virus 0.320818 hepatitis aguda 0.31315 prospective study 0.328899	CLICK HERE
15650	National Cancer Institute	Html	en	Step 2: Application Receipt & Assignment	Information on the assignment numbers the Center for Scientific Review (CSR) creates once an application is submitted and other submission policies.	Application Type 0.237536 100,228th application 0.228911 program director 0.554123 peer review process 0.902016 initial peer review 0.326681 Scientific Review 0.216004 new application 0.239088 specific application 0.226573 Resubmission Applications 0.206964 research grant applications 0.359218 his/her assigned application 0.489157 specific budgetary limits 0.31822 Program Announcements 0.201839	pre-announced Request 0.201939 appropriate application form 0.353459 new grant 0.218872 NIH peer review 0.369648 Incomplete applications 0.208003 NCI program director 0.428336 suffix code 0.378185 grant numbers 0.228139 application 0.702093 NIH Policy 0.353037 traditional research project 0.330544 central receipt point 0.406816	CLICK HERE
16830	National Cancer Institute	Html	en	Clinical Trial Sequencing Project	null	gene expression test 0.968523 vital genomic information 0.445867 non-metastatic RCC 0.377128 breast cancer response 0.478667 Large B Cell 0.384272 NCTN clinical trials 0.448807 ECOG-ACRIN E2805 trial 0.421922 DLBCL patients 0.352651 National Clinical Trials 0.46574 molecular basis 0.431838 advanced RCC 0.374566 clinical trials 0.533121 VEGF inhibitors 0.375945 clinical trial 0.642586 RCC development 0.370697 breast cancer patients 0.519364 comprehensive molecular analysis 0.404401 Genomic Data Commons 0.460933 Trial Assigning Individualized 0.463121 cancer types 0.360865 surgical removal 0.412464 chemotherapy best complements 0.471441 large B-cell lymphoma 0.45172 cancer recurrence 0.405985 low-risk patients 0.363667	clinically helpful tool 0.4004 rich molecular data 0.400698 Combination Chemotherapy 0.375651 cancer research community 0.644574 adult non-Hodgkin lymphoma 0.414301 Her2-negative breast cancer 0.645596 NCI-sponsored clinical trial 0.620071 common kidney cancer 0.437411 endothelial growth factor 0.403689 different chemotherapy regimens 0.474741 human epidermal growth 0.418539 anonymized clinical data 0.446701 genomic alterations 0.360205 CCG 0.375478 NCI-sponsored clinical trials 0.472546 pathway drives RCC 0.461359 breast cancer 0.780189 best individualized treatment 0.43596 Clinical Trial Sequencing 0.508554 tissue samples 0.518757 breast cancer treatments 0.478341 renal cell carcinoma 0.625007 New England Journal 0.405702 Diffuse Large 0.405055	CLICK HERE
16857	National Cancer Institute	Html	en	Prior Approval Requests	null	recipient institution 0.428349 current policies 0.408224 NoA 0.327733 NIH recipients 0.49032 enforcement action 0.408587 latitude 0.326586 prior approval requests 0.721397 specific prior approval 0.686294 grants management specialist 0.645519 certain degree 0.434218 copies 0.318206 prior approval authority 0.69999 terms 0.318069 prior approval 0.984844 unanticipated requirements 0.40335 total costs 0.405045 Questions 0.317851 makes certain budget 0.539233 NIH Grants Policy 0.559485 limits 0.321806 email 0.319573 recipient’s discretion 0.470347 cc 0.322104	termination 0.321773 Circumstances 0.323427 types 0.321678 cases 0.320114 subject line 0.413724 budget categories 0.540205 Statement 0.318087 GMO 0.360575 disallowance 0.318052 grants management officer 0.531732 proposed change 0.416195 agency authority 0.407763 NCI program director 0.515619 unauthorized officials 0.411596 PD/PI 0.318695 undertakes particular activities 0.523 expenditures 0.324868 response 0.318742 post-award changes 0.427573 grant number 0.410914 unanticipated needs 0.427883 responses 0.319676 risk 0.318261	CLICK HERE
17243	National Cancer Institute	Html	es	Conversación sobre el cáncer avanzado	Aprenda formas de comunicarse con su médico y con sus seres queridos, y cómo recibir apoyo si tiene cáncer avanzado.	cuánto tiempo 0.910821 Dígales cuáles 0.675552 Is Being Treated 0.579455 Someone You Love 0.717833	inglés when someone 0.582776 Mucha gente 0.551036 When Someone You 0.727905 Deles tiempo 0.577854	CLICK HERE